Company / Free Cash Flow per Share
Bicara Therapeutics Inc. Free Cash Flow per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.00
FY2024
5-year range
-$0.08 / -$0.00
FY2023-FY2024
Trend
+94.4%
vs FY2023
Sector context
#67 of 192
Health Care
What the data says
At $-0.00, Bicara Therapeutics Inc.'s free cash flow per share ranks #67 of 192 in the Health Care sector.
Based on SEC 10-K filings.
-0.00 in FY2024.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#67 of 192 in Health CareTop 35% of 192This company -$0.00 Sector average $3.32
▼
-100.1% below sector average
Key checks
Key Insights
- In FY2024, free cash flow per share increased 94.4% year-over-year.
- Ranks #67 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.00 | +94.4% |
| FY2023 | -$0.08 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026